| Product Code: ETC8858501 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Poland Cancer Treatment Market Overview |
3.1 Poland Country Macro Economic Indicators |
3.2 Poland Cancer Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Poland Cancer Treatment Market - Industry Life Cycle |
3.4 Poland Cancer Treatment Market - Porter's Five Forces |
3.5 Poland Cancer Treatment Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.6 Poland Cancer Treatment Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Poland Cancer Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Poland Cancer Treatment Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Poland Cancer Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Poland |
4.2.2 Technological advancements in cancer treatment |
4.2.3 Growing investments in healthcare infrastructure in Poland |
4.3 Market Restraints |
4.3.1 High cost of cancer treatments |
4.3.2 Limited access to advanced treatment options in certain regions of Poland |
4.3.3 Stringent regulatory requirements for cancer treatment drugs and therapies |
5 Poland Cancer Treatment Market Trends |
6 Poland Cancer Treatment Market, By Types |
6.1 Poland Cancer Treatment Market, By Cancer Type |
6.1.1 Overview and Analysis |
6.1.2 Poland Cancer Treatment Market Revenues & Volume, By Cancer Type, 2021- 2031F |
6.1.3 Poland Cancer Treatment Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.1.4 Poland Cancer Treatment Market Revenues & Volume, By Colorectal Cancer with Liver Metastases, 2021- 2031F |
6.1.5 Poland Cancer Treatment Market Revenues & Volume, By Lung Carcinoma, 2021- 2031F |
6.1.6 Poland Cancer Treatment Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.1.7 Poland Cancer Treatment Market Revenues & Volume, By Ovarian Cancer, 2021- 2031F |
6.1.8 Poland Cancer Treatment Market Revenues & Volume, By Head-And-Neck Cancer, 2021- 2031F |
6.1.9 Poland Cancer Treatment Market Revenues & Volume, By Glioblastoma, 2021- 2031F |
6.1.10 Poland Cancer Treatment Market Revenues & Volume, By Glioblastoma, 2021- 2031F |
6.2 Poland Cancer Treatment Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Poland Cancer Treatment Market Revenues & Volume, By Medication, 2021- 2031F |
6.2.3 Poland Cancer Treatment Market Revenues & Volume, By Targeted Therapies, 2021- 2031F |
6.2.4 Poland Cancer Treatment Market Revenues & Volume, By Radiotherapy, 2021- 2031F |
6.2.5 Poland Cancer Treatment Market Revenues & Volume, By Surgery, 2021- 2031F |
6.3 Poland Cancer Treatment Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Poland Cancer Treatment Market Revenues & Volume, By Injectable, 2021- 2031F |
6.3.3 Poland Cancer Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.4 Poland Cancer Treatment Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Poland Cancer Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Poland Cancer Treatment Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
7 Poland Cancer Treatment Market Import-Export Trade Statistics |
7.1 Poland Cancer Treatment Market Export to Major Countries |
7.2 Poland Cancer Treatment Market Imports from Major Countries |
8 Poland Cancer Treatment Market Key Performance Indicators |
8.1 Average waiting time for cancer treatment |
8.2 Adoption rate of new cancer treatment technologies in Poland |
8.3 Number of clinical trials for cancer treatments conducted in Poland |
9 Poland Cancer Treatment Market - Opportunity Assessment |
9.1 Poland Cancer Treatment Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.2 Poland Cancer Treatment Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Poland Cancer Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Poland Cancer Treatment Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Poland Cancer Treatment Market - Competitive Landscape |
10.1 Poland Cancer Treatment Market Revenue Share, By Companies, 2024 |
10.2 Poland Cancer Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here